col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Rheumatology International
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown Grace Johnstone, Gareth J. Treharne, Benjamin D. Fletcher, Roisin S. M. Lamar, Douglas White, Andrew Harrison, Simon Stebbings
2 [GO] 2021―Jul―22 Correction to: COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis? Bahar Özdemir, Abdulsamet Erden, Serdar Can Güven, Berkan Armagan, Hakan Apaydin, Özlem Karakas, et al. (+4)
3 [GO] 2021―Jul―22 Correction to: Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection Sibabratta Patnaik, Mukesh Kumar Jain, Sakir Ahmed, Arun Kumar Dash, Ram Kumar P, Bandya Sahoo, et al. (+2)
4 [GO] 2021―Jul―14 Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection Sibabratta Patnaik, Mukesh Kumar Jain, Sakir Ahmed, Arun Kumar Dash, Ram Kumar P, Bandya Sahoo, et al. (+2)
5 [GO] 2021―Jul―09 Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt Nevin Hammam, Samar Tharwat, Rawhya R. El Shereef, Ahmed M. Elsaman, Noha M. Khalil, Hanan M. Fathi, et al. (+29)
6 [GO] 2021―Jul―02 COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey Priyanka Gaur, Hardik Agrawat, Anuj Shukla
7 [GO] 2021―Jun―17 Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey Somy Cherian, Aby Paul, Sakir Ahmed, Bazil Alias, Manesh Manoj, Ansu K. Santhosh, et al. (+3)
8 [GO] 2021―Jun―10 Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective Javeria Tariq, Latika Gupta
9 [GO] 2021―Jun―09 Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly Emire Seyahi, Guldaran Bakhdiyarli, Mert Oztas, Mert Ahmet Kuskucu, Yesim Tok, Necdet Sut, et al. (+6)
10 [GO] 2021―Jun―07 ANCA-associated vasculitis after COVID-19 Tugba Izci Duran, Ercan Turkmen, Melda Dilek, Hayriye Sayarlioglu, Nurol Arik
11 [GO] 2021―Jun―06 COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review Alicia Rodriguez-Pla, Holenarasipur R. Vikram, Vanood Khalid, Lewis J. Wesselius
12 [GO] 2021―Jun―05 COVID-19 in patients with gout on colchicine Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari, Alexandros A. Drosos
13 [GO] 2021―May―25 COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis? Bahar Özdemir, Abdulsamet Erden, Serdar Can Güven, Berkan Armagan, Hakan Apaydin, Özlem Karakas, et al. (+4)
14 [GO] 2021―May―25 The impact of COVID-19 on familial Mediterranean fever: a nationwide study Zafer Günendi, Fatma Gül Yurdakul, Hatice Bodur, Ahmet Kıvanç Cengiz, Ülkü Uçar, Hasan Fatih Çay, et al. (+20)
15 [GO] 2021―May―12 Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews Fatih Karaarslan, Fulya Demircioğlu Güneri, Sinan Kardeş
16 [GO] 2021―May―05 Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study Mostafa Najim, Alaa Rahhal, Fadi Khir, Amer Hussien Aljundi, Safae Abu Yousef, Feryal Ibrahim, et al. (+9)
17 [GO] 2021―May―04 Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting Michel Chevallard, Laura Belloli, Nicola Ughi, Antonella Adinolfi, Cinzia Casu, Maria Di Cicco, et al. (+12)
18 [GO] 2021―Apr―26 Sex hormones, autoimmunity and gender disparity in COVID-19 Hussain Ahmed Raza, Parikshit Sen, Omaima Anis Bhatti, Latika Gupta
19 [GO] 2021―Apr―15 Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases Zeyad A. Alzahrani, Khalid Abdullah Alghamdi, Ahmed Saeed Almaqati
20 [GO] 2021―Apr―12 COVID-19 pandemic and systemic autoinflammatory diseases management: a cross-sectional survey Na Wu, Mengzhu Zhao, Di Wu, Keyi Yu, Min Shen
21 [GO] 2021―Mar―29 Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey Berna Yurttas, Burc Cagri Poyraz, Necdet Sut, Ayse Ozdede, Mert Oztas, Serdal Uğurlu, et al. (+3)
22 [GO] 2021―Mar―27 Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry Pankti Mehta, Pedro M. Machado, Latika Gupta
23 [GO] 2021―Mar―19 Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent Aliye Bastug, Halide Aslaner, Yesim Aybar Bilir, Nizamettin Kemirtlek, Fahriye Melis Gursoy, Serdal Bastug, Hurrem Bodur
24 [GO] 2021―Mar―12 Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions Ansh Bhatia, Manish KC, Latika Gupta
25 [GO] 2021―Mar―09 Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis Qingxiu Wang, Jianbo Liu, Runxia Shao, Xiaopeng Han, Chenhao Su, Wenjia Lu
26 [GO] 2021―Mar―08 Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists Ales Janda, Catharina Schuetz, Scott Canna, Mark Gorelik, Maximilian Heeg, Kirsten Minden, et al. (+5)
27 [GO] 2021―Mar―05 Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19 Nourhane Nasser, Mazen Kurban, Ossama Abbas
28 [GO] 2021―Mar―04 Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study George E. Fragoulis, Ioannis Grigoropoulos, Evgenia Mavrea, Aikaterini Arida, Vassiliki-Kalliopi Bournia, Gerasimos Evangelatos, et al. (+10)
29 [GO] 2021―Mar―03 Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience Michalis P. Migkos, Evripidis Kaltsonoudis, Eleftherios Pelechas, Vassiliki Drossou, Panagiota G. Karagianni, Athanasios Kavvadias, et al. (+2)
30 [GO] 2021―Feb―21 COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review Kemal Nas, Nuran Eryilmaz, Mehmet Faruk Geyik, Ayfer Altaş
31 [GO] 2021―Feb―21 COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study Serdar Can Güven, Abdulsamet Erden, Özlem Karakaş, Berkan Armağan, Eren Usul, Ahmet Omma, Orhan Küçükşahin
32 [GO] 2021―Feb―10 The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding N. Cleaton, S. Raizada, N. Barkham, S. Venkatachalam, T. P. Sheeran, T. Adizie, et al. (+3)
33 [GO] 2021―Feb―04 Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review Abraham Edgar Gracia-Ramos, Miguel Ángel Saavedra-Salinas
34 [GO] 2021―Jan―30 SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis Tsvetelina Velikova, Tsvetoslav Georgiev
35 [GO] 2021―Jan―27 Enhancing rheumatology education during the COVID-19 pandemic Saira Bilal, Victoria K. Shanmugam
36 [GO] 2021―Jan―27 Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents Gizem Durcan, Kenan Barut, Fatih Haslak, Hilal Doktur, Mehmet Yildiz, Amra Adrovic, et al. (+2)
37 [GO] 2021―Jan―15 Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands Wouter H. Bos, Astrid van Tubergen, Harald E. Vonkeman
38 [GO] 2021―Jan―03 Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic Sakir Ahmed, Armen Yuri Gasparyan, Olena Zimba
39 [GO] 2021―Jan―03 Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis-ITIE” Emre Bilgin, Ali İhsan Ertenli
40 [GO] 2021―Jan―02 Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19 Chia Siang Kow, Syed Shahzad Hasan
41 [GO] 2021―Jan―01 COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases Hussain Ahmed Raza, Javeria Tariq, Vikas Agarwal, Latika Gupta
42 [GO] 2020―Nov―30 Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19 Sophia M. Brady, Sally A. M. Fenton, George S. Metsios, Ailsa Bosworth, Joan L. Duda, George D. Kitas, Jet J. C. S. Veldhuijzen van Zanten
43 [GO] 2020―Nov―21 Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management Jayakanthan Kabeerdoss, Rakesh Kumar Pilania, Reena Karkhele, T. Sathish Kumar, Debashish Danda, Surjit Singh
44 [GO] 2020―Nov―17 COVID-19 pandemic in Japan Olga Amengual, Tatsuya Atsumi
45 [GO] 2020―Nov―07 Building trust in journals and in peer review: need of the hour during the COVID-19 pandemic Sakir Ahmed
46 [GO] 2020―Nov―04 Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic R. Naveen, T. G. Sundaram, Vikas Agarwal, Latika Gupta
47 [GO] 2020―Nov―01 Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient Esam Abualfadl, Faten Ismail, Rawhya R. El Shereef, Eman Hassan, Samar Tharwat, Eman F. Mohamed, et al. (+14)
48 [GO] 2020―Oct―18 COVID-19 in Italian Sjögren's syndrome patients: a monocentric study F. Giardina, R. Izzo, A. Gattamelata, S. Colafrancesco, F. Conti, R. Priori
49 [GO] 2020―Oct―18 Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends Sinan Kardeş, Ali Suat Kuzu, Rahul Raiker, Haig Pakhchanian, Mine Karagülle
50 [GO] 2020―Oct―13 Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists Latika Gupta, Armen Yuri Gasparyan, Olena Zimba, Durga Prasanna Misra
51 [GO] 2020―Oct―12 Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease Chia Siang Kow, Syed Shahzad Hasan
52 [GO] 2020―Sep―29 #Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic Nikolas Ruffer, Johannes Knitza, Martin Krusche
53 [GO] 2020―Sep―18 High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study Jesús Loarce-Martos, Antía García-Fernández, Fernando López-Gutiérrez, Verónica García-García, Laura Calvo-Sanz, Iván del Bosque-Granero, et al. (+4)
54 [GO] 2020―Sep―16 Kawasaki-like disease in children with COVID-19 Ummusen Kaya Akca, Selman Kesici, Yasemin Ozsurekci, Hayrettin Hakan Aykan, Ezgi Deniz Batu, Erdal Atalay, et al. (+6)
55 [GO] 2020―Sep―15 Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases Vladimira Vasileva Boyadzhieva, Nikolay Rumenov Stoilov, Rumen Malinov Stoilov
56 [GO] 2020―Aug―13 Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes Fernando Montero, Julia Martínez-Barrio, Belén Serrano-Benavente, Teresa González, Javier Rivera, Juan Molina Collada, et al. (+2)
57 [GO] 2020―Aug―02 Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19 Oya Koker, Fatma Gul Demirkan, Gulsah Kayaalp, Figen Cakmak, Ayse Tanatar, Serife Gul Karadag, et al. (+3)
58 [GO] 2020―Jul―24 Rheumatologists’ practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt Tamer A. Gheita, Mohamed N. Salem, Nahla N. Eesa, Noha M. Khalil, Nada M. Gamal, Rasha Abdel Noor, et al. (+26)
59 [GO] 2020―Jul―14 Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic Francesco Masini, Klodian Gjeloshi, Roberta Ferrara, Emanuele Pinotti, Giovanna Cuomo
60 [GO] 2020―Jul―14 Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment Sanket Shah, Debashish Danda, Chengappa Kavadichanda, Saibal Das, M. B. Adarsh, Vir Singh Negi
61 [GO] 2020―Jul―13 Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic Fatih Haslak, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Oya Koker, Ayten Aliyeva, et al. (+2)
62 [GO] 2020―Jul―11 Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes Efstathios Kastritis, George D. Kitas, Dimitrios Vassilopoulos, Georgios Giannopoulos, Meletios A. Dimopoulos, Petros P. Sfikakis
63 [GO] 2020―Jun―26 Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review Ilke Coskun Benlidayi, Behice Kurtaran, Emre Tirasci, Rengin Guzel
64 [GO] 2020―Jun―25 Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic Mehmet Soy, Pamir Atagündüz, Işık Atagündüz, Gülsan Türköz Sucak
65 [GO] 2020―Jun―22 The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey Emire Seyahi, Burc Cagri Poyraz, Necdet Sut, Selma Akdogan, Vedat Hamuryudan
66 [GO] 2020―Jun―12 Targeting the immunology of coronavirus disease-19: synchronization creates symphony Sakir Ahmed, Prajna Anirvan
67 [GO] 2020―Jun―08 Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic Zaure Mukusheva, Maikesh Assylbekova, Dimitri Poddighe
68 [GO] 2020―Jun―04 Implications of COVID-19 in pediatric rheumatology Ezgi Deniz Batu, Seza Özen
69 [GO] 2020―Jun―02 Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic Hyun-Sook Kim, Myeung-Su Lee, HyungJin Kim, Yoon-Kyoung Sung, Jisoo Lee, Seung-Cheol Shim, et al. (+2)
70 [GO] 2020―May―15 Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19) Erkan Cure, Adem Kucuk, Medine Cumhur Cure
71 [GO] 2020―Apr―20 Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs Jehun Song, Seongmin Kang, Seung Won Choi, Kwang Won Seo, Sunggun Lee, Min Wook So, Doo-Ho Lim
72 [GO] 2020―Mar―30 Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs Tsvetoslav Georgiev
73 [GO] 2020―Mar―30 COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone
74 [GO] 2020―Mar―28 Arthralgia as an initial presentation of COVID-19: observation Beuy Joob, Viroj Wiwanitkit


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.013 sec